On Invalid Date, Utah Medical Products (NASDAQ: UTMD) reported Q4 2023 earnings per share (EPS) of $1.18, up 6.35% year over year. Total Utah Medical Products earnings for the quarter were $4.29 million. In the same quarter last year, Utah Medical Products's earnings per share (EPS) was $1.26.
As of Q2 2024, Utah Medical Products's earnings has grown 1.1% year over year. This is 26.6 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.71%. Utah Medical Products's earnings in the past year totalled $16.64 million.
What is UTMD's earnings date?
Utah Medical Products's earnings date is Invalid Date. Add UTMD to your watchlist to be reminded of UTMD's next earnings announcement.
What was UTMD's revenue last quarter?
On Invalid Date, Utah Medical Products (NASDAQ: UTMD) reported Q4 2023 revenue of $12.33 million up 9.14% year over year. In the same quarter last year, Utah Medical Products's revenue was $13.57 million.
What was UTMD's revenue growth in the past year?
As of Q2 2024, Utah Medical Products's revenue has grown -3.93% year over year. This is 11.46 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Utah Medical Products's revenue in the past year totalled $50.22 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.